Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

7.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
7.0K
Redox Reactions01:24

Redox Reactions

59.6K
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
59.6K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

2.6K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strengthening the Leader Within: A Deep Dive into Impact of Yoga on Various Leadership Traits - A Narrative Review.

Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine·2026
Same author

Structural Characterization of the Type IV Secretion System in <i>Brucella melitensis</i> for Virtual Screening-Based Therapeutic Targeting.

Journal of chemical information and modeling·2026
Same author

Variation in <i>SNX29</i> and Acute Vasodilator Response in Pulmonary Arterial Hypertension.

Circulation research·2026
Same author

Adverse Cardiac Effects of Ultrasonic Vaping Devices Despite Lack of Heating Coil.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Plasma Cytokine and Chemokine Profile in Hospitalized Toxic Epidermal Necrolysis Patients.

Clinical and experimental dermatology·2026
Same author

Review of Prognosis Approaches Applied to Power SiC MOSFETs for Health State and Remaining Useful Life Prediction.

Entropy (Basel, Switzerland)·2026

Related Experiment Video

Updated: Apr 20, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO&#8226;) Probes, the geNOps, for Real-time Imaging of NO&#8226; Signals in Single Cells
08:32

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells

Published on: March 16, 2017

13.5K

Protein engineering to develop a redox insensitive endothelial nitric oxide synthase.

Ruslan Rafikov1, Sanjiv Kumar1, Saurabh Aggarwal1

  • 1Pulmonary Vascular Disease, Vascular Biology Center, Georgia Regents University, Augusta, GA, USA.

Redox Biology
|December 3, 2014
PubMed
Summary

Researchers created a stable endothelial nitric oxide synthase (eNOS) mutant by replacing sensitive cysteines with arginines. This engineered eNOS resists oxidative stress, maintaining cell function and offering potential therapeutic applications for related diseases.

Keywords:
Endothelial nitric oxide synthaseProtein engineeringRedox stabilityZinc tetrathiolate cluster

More Related Videos

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

10.2K
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

5.0K

Related Experiment Videos

Last Updated: Apr 20, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO&#8226;) Probes, the geNOps, for Real-time Imaging of NO&#8226; Signals in Single Cells
08:32

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells

Published on: March 16, 2017

13.5K
En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

10.2K
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

5.0K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Endothelial nitric oxide synthase (eNOS) contains a zinc tetrathiolate (ZnS4) cluster crucial for its structure.
  • This ZnS4 cluster, formed by cysteine residues at the dimeric interface, is sensitive to oxidants and causes eNOS dimer destabilization under redox stress.
  • Oxidative stress-induced eNOS dysfunction contributes to various diseases.

Purpose of the Study:

  • To investigate the role of the ZnS4 cluster in eNOS stability and function.
  • To develop a redox-stable eNOS mutant resistant to oxidative damage.
  • To evaluate the therapeutic potential of a stabilized eNOS variant.

Main Methods:

  • Site-directed mutagenesis was used to replace redox-sensitive cysteine residues (C94, C99) with redox-stable tetra-arginines, creating the C94R/C99R eNOS mutant.
  • The activity and stability of the C94R/C99R mutant were assessed under oxidative stress conditions (hydrogen peroxide).
  • Overexpression of the mutant in endothelial cells was used to evaluate its effect on angiogenic responses, cell migration, and monolayer integrity.

Main Results:

  • The C94R/C99R eNOS mutant demonstrated retained enzymatic activity.
  • This mutant protein was insensitive to dimer disruption and inhibition by hydrogen peroxide.
  • Overexpression of the C94R/C99R mutant preserved endothelial cell angiogenic response, migration, and monolayer integrity under oxidative stress.

Conclusions:

  • The engineered C94R/C99R eNOS mutant exhibits enhanced stability against oxidative stress.
  • This dimer-stable eNOS mutant holds promise for treating diseases associated with eNOS dysfunction and high oxidative stress.
  • Targeting eNOS stability offers a potential therapeutic strategy for managing oxidative stress-related vascular pathologies.